US 9556133
Polycyclic LPA1 antagonist and uses thereof
granted A61PA61P35/00A61P37/00
Quick answer
US patent 9556133 (Polycyclic LPA1 antagonist and uses thereof) held by AMIRA PHARMACEUTICALS, INC. expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AMIRA PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P35/00, A61P37/00, A61P37/08, A61P43/00